Tuesday, April 28
7:00 am - 9:00 am
Location: 151B; BCEC
Advanced Practice Provider Fee: $150
Candidate and Medical Student Fee: $65
Moderator(s): Steven N. Kalkanis, MD, FAANS
Panelist(s): Andrew J. Fabiano, MD, FAANS; Brian Vala Nahed, MD, FAANS ; Jeffrey J. Olson, MD, FAANS; Claudio G. Yampolsky, MD, IFAANS (Argentina)
Brain metastases (BM) are commonly treated as a part of a general neurosurgical practice. Major changes in the management of brain metastases have occurred in the past decade. This course covers the management of brain metastases including:
- Stereotactic Radiosurgery (SR);
- Post-SR Metastases;
- Surgical Resection of BM from Eloquent Cortex;
- Targeted Therapy;
- Interactive Case Presentations to interactively discuss different management strategies.
Learning Objectives: After completing this educational activity, participants should be able to:
- Describe advanced management strategies for brain metastases including resection from eloquent cortex, stereotactic radiosurgery, and immune therapy.
- Describe complex stereotactic radiosurgical planning for large metastases, brainstem metastases, and cavities before and after resection.
- Diagnose and manage post-stereotactic radiosurgery brain metastases. Describe the advantages and shortcomings of neuroimaging techniques.
- Develop an understanding of the role LITT and bevacizumab has in the treatment of post-SR brain metastases.
- Describe the current literature on the role of immune therapy as a primary treatment for brain metastases. Discuss current treatment algorithms for BM of various primary tumor types that incorporate immune therapies.